<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">World J Surg Oncol</journal-id>
      <journal-title>World Journal of Surgical Oncology</journal-title>
      <issn pub-type="epub">1477-7819</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18279529</article-id>
      <article-id pub-id-type="pmc">2288607</article-id>
      <article-id pub-id-type="publisher-id">1477-7819-6-20</article-id>
      <article-id pub-id-type="doi">10.1186/1477-7819-6-20</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Correspondence</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Correspondence: Prostatic sarcoma after treatment for rectal cancer</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" contrib-type="author">
          <name>
            <surname>Aherne</surname>
            <given-names>Noel J</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>noelaherne@eircom.net</email>
        </contrib>
        <contrib id="A2" corresp="yes" contrib-type="author">
          <name>
            <surname>Gillham</surname>
            <given-names>Charles M</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>cmgillham@yahoo.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Radiation Oncology, St. Luke's Hospital, Dublin 6, Ireland</aff>
      <pub-date pub-type="collection">
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>2</month>
        <year>2008</year>
      </pub-date>
      <volume>6</volume>
      <fpage>20</fpage>
      <lpage>20</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.wjso.com/content/6/1/20"/>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>9</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>2</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2008 Aherne and Gillham; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <copyright-holder>Aherne and Gillham; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Aherne
               J
               Noel
               
               noelaherne@eircom.net
            </dc:author><dc:title>
            Correspondence: Prostatic sarcoma after treatment for rectal cancer
         </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>World Journal of Surgical Oncology 6(1): 20-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1477-7819(2008)6:1&#x0003c;20&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1477-7819</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <sec>
      <title/>
      <p>Dear Sirs,</p>
      <p>The authors Abbas SM, and Hill AG [<xref ref-type="bibr" rid="B1">1</xref>] outline their experience of a case of prostatic sarcoma occurring four years post neoadjuvant radiation therapy for primary mid rectal adenocarcinoma. They correctly state that as this second malignancy occurred within the radiation field it meets the criteria for a radiation &#x2013; induced second malignancy. However, it has been noted that while there is no established dose response relationship for sarcoma that they are generally felt to occur within the high dose region. A dose of 4500 cGy seems unlikely to lead to sarcoma formation within such a short time frame.</p>
      <p>While post radiation sarcomas have commonly been described in the pelvis they more commonly follow high dose 3 Dimensional Conformal Radiation therapy (3DCRT) with or without intracavitary brachytherapy (doses &gt; 7000 cGy) in gynecological cancers, or in combination with interstitial seed brachytherapy (doses &gt; 1000 cGy) in prostatic malignancy. In contrast, primary prostatic sarcoma is a well recognized clinical entity with over 50 cases recorded in the literature [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>].</p>
      <p>While the author's assertion that this is a radiation induced second malignancy is supported by the temporal association, radiobiologically it is not. However, this case is a salient reminder of the significant risks associated with all forms of cancer therapy.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>NJA: Conception and design, editing of manuscript.</p>
      <p>CMG: preparation of draft manuscript.</p>
      <p>All authors read and approved final manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abbas</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
          <article-title>Prostatic sarcoma after treatment of rectal cancer</article-title>
          <source>World Journal of Surgical Oncology</source>
          <year>2007</year>
          <volume>5</volume>
          <fpage>82</fpage>
          <pub-id pub-id-type="pmid">17663758</pub-id>
          <pub-id pub-id-type="doi">10.1186/1477-7819-5-82</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sexton</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Lance</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Reyes</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Pisters</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Tu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pisters</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Adult Prostate Sarcoma: The M.D Anderson cancer centre experience</article-title>
          <source>J Urol</source>
          <year>2001</year>
          <volume>166</volume>
          <fpage>521</fpage>
          <lpage>525</lpage>
          <pub-id pub-id-type="pmid">11458058</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0022-5347(05)65974-5</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheville</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Dundore</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Nascimento</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Meneses</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kleer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Farrow</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Bostwick</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <article-title>Leiomyosarcoma of prostate: Report of 23 cases</article-title>
          <source>Cancer</source>
          <year>1995</year>
          <volume>76</volume>
          <fpage>1422</fpage>
          <lpage>1477</lpage>
          <pub-id pub-id-type="pmid">8620418</pub-id>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19951015)76:8&lt;1422::AID-CNCR2820760819&gt;3.0.CO;2-L</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mansouri</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kanouni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kebdani</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hassouni</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sifat</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gueddari</surname>
              <given-names>BE</given-names>
            </name>
          </person-group>
          <article-title>Primary prostatic leiomyosarcoma</article-title>
          <source>J Urol</source>
          <year>2001</year>
          <volume>165</volume>
          <fpage>1676</fpage>
          <pub-id pub-id-type="pmid">11342954</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0022-5347(05)66390-2</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
